Advertisement
Advertisement

QNCX

QNCX logo

Quince Therapeutics, Inc. Common Stock

1.28
USD
Sponsored
-0.02
-1.54%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

1.28

0.00
+0.39%

Quince Therapeutics, Inc. Common Stock Profile

About

Quince Therapeutics Inc. is a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases. The company's product pipeline includes NOV004. Quince Therapeutics Inc., formerly known as Cortexyme Inc., is based in Calif.

Info & Links

CEO

Dirk Thye

Headquarters

611 GATEWAY BOULEVARD, SUITE 273
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.quincetx.com

Auditor

BDO USA, P.C.

Share holders

28

Employees

38

Quince Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

20.95M

Enterprise Value

33.16M

Enterprise Value/EBITDA(ttm)

-0.56

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

6.37

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-372.88%

Return on Invested Capital(ttm)

-1397.60%

Return on Assets(ttm)

-51.13%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-58.94M

Net Income Available to Common(ttm)

-83.98M

Diluted EPS(ttm)

-1.21

Share Statistics

Beta (5Y Monthly)

1.33

52-Week Change

-87.57%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

16.30M

Dividend Yield

0.00%

Float4

44.38M

% Held by Insiders

20.30%

% Held by Institutions

30.75%

Balance Sheet

Total Cash(mrq)

17.75M

Total Cash Per Share(mrq)

1.09

Total Debt(mrq)

18.03M

Total Debt/Equity(mrq)

1654.39%

Current Ratio(mrq)

1.12%

Quick Ratio(mrq)

1.12%

Book Value Per Share(mrq)

0.02

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.57

Free Cash Flow(ytd)

-31.29M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement